KemPharm, Inc. , a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced the addition of a new product candidate, KP879, which the company plans to develop as an extended-duration, agonist replacement therapy for the treatment of Stimulant Use Disorder (SUD).

PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy , and RxCrossroads  by McKesson, the leading commercial solutions partner for life sciences companies, announced their collaborative program to simplify the channel for precision medicine therapies.

Medigene AG announced that it has entered into an exclusive license agreement with Leiden University Medical Center, the Netherlands, for worldwide rights to develop, manufacture, and commercialize an HA-1-specific T cell receptor (TCR) as a targeted immunotherapy for cancer.

AbbVie , a research-based global biopharmaceutical company, announced the decision to stop enrollment for the TAHOE trial, a Phase 3 study evaluating Rovalpituzumab Tesirine (Rova-T) as a second-line therapy for advanced small-cell lung cancer (SCLC).

AstraZeneca and MedImmune, its global biologics research and development arm, announced final overall survival (OS) results for the Phase III MYSTIC trial.

Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for oncology, infectious diseases and vaccines, and rare and orphan diseases, extends its congratulations to Ablynx, a Sanofi company, for its launch of Cablivi® (caplacizumab) in the German market for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP).

Recro Gainesville has added a 24,000-square-foot facility, which includes high-potent material processing space, near its existing 97,000-square-foot contract pharmaceutical development and manufacturing plant.

Sirio Pharma Co. Ltd (SIRIO) – the global nutraceutical contract development and manufacturing organization (CDMO) announces the opening of a gummy production plant at its new development and manufacturing facility in Ma’anshan (300km West of Shanghai, China).

Multisorb, the leading provider of oxygen and moisture management technologies, announced the inauguration of a new manufacturing facility in Hyderabad, India.

Lonza is highlighting its next-generation clean label dosage form capabilities at this year’s Hi Europe from 27-29 November 2018 in Frankfurt (DE).

They’ve extended their industry leading position for product security for global medicines with significant Serialization and Anticounterfeiting technology investment.

ALLpaQ has announced a new partnership with ESI Technologies. This agreement will position ESI as distributor of ALLpaQ’s bioprocess tote and single-use technology solutions in Ireland, UK and the Benelux.